Bioactive Natural Products for the Management of Cancer: From Bench to Bedside 2019
DOI: 10.1007/978-981-13-7607-8_7
|View full text |Cite
|
Sign up to set email alerts
|

Immunomodulatory and Therapeutic Potential of Marine Flora Products in the Treatment of Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 176 publications
0
6
0
Order By: Relevance
“…are the persuasive antitumor chemical representatives which can act as encouraging anticancerous agent (Haq et al 2019 ). Moreover, cryptophycin 1 and borophycin isolated from Nostoc indicated anti-tumorigenic activity against human tumor cells, and KB and LoVo cell lines, respectively (Singh and Krishna 2019 ). Recently, it has been reported that methanolic extract (T1) of H. pulvialis showed anticancerous activity by suppressing invasion of breast cancer cells (MDA-MB-231) and promoting apoptosis through biochemical pathway involving p53/Bax/Bcl2 (Alateyah et al 2022 ).…”
Section: Microalgal Bioactive Compounds and Their Potential Biologica...mentioning
confidence: 99%
“…are the persuasive antitumor chemical representatives which can act as encouraging anticancerous agent (Haq et al 2019 ). Moreover, cryptophycin 1 and borophycin isolated from Nostoc indicated anti-tumorigenic activity against human tumor cells, and KB and LoVo cell lines, respectively (Singh and Krishna 2019 ). Recently, it has been reported that methanolic extract (T1) of H. pulvialis showed anticancerous activity by suppressing invasion of breast cancer cells (MDA-MB-231) and promoting apoptosis through biochemical pathway involving p53/Bax/Bcl2 (Alateyah et al 2022 ).…”
Section: Microalgal Bioactive Compounds and Their Potential Biologica...mentioning
confidence: 99%
“…Worthy of mention is that several anticancer drugs of marine origin are in clinical use with sufficient approvals, including cytarabine, vidarabine, nelarabine, fludarabine phosphate, trabectedin, eribulin mesylate, brentuximab vedotin, polatuzumabvedotin, enfortumabvedotin, belantamabmafodotin, plitidepsin, lurbinectedin, bryostatins, discodermolide, eleutherobin, and sarcodictyin [41,58]. such as Lactobacilli and Bifidobacteria, modify the mucosa by increasing the production of chemokines and host defense peptides, inducing dendritic cell maturation, and increasing cell proliferation and apoptosis [51]. Marine probiotics can modulate cancer by inducing apoptosis, inhibiting mutagenic activity, downregulating oncogene expression, inducing autophagy, inhibiting kinases, reactivating tumor suppressors, preventing metastasis, and producing meta-biotics, as already shown in B. animalis, B. infantis, B. bifidum, L. paracasei, L. acidophilus, and L. plantarum I-UL4 against MFC7 cancer cells [53,54].…”
Section: Marine Probiotics and General Therapeutic Potentialsmentioning
confidence: 99%
“…Trioxacarcins A–C, anthraquinone, Macrodiolide tartrolon D, and Streptokordin obtained from Streptomyces spp. exhibited significant antitumor/cytotoxic activities against various cancer cell lines [ 50 , 51 , 52 ].…”
Section: Marine Probiotics and General Therapeutic Potentialsmentioning
confidence: 99%
See 1 more Smart Citation
“…An immunomodulator is a compound that can modify the activity of the immune system by enhancing or suppressing the host response and are categorized as an Immunostimulant, immunosuppressant and immunoadjuvant (Sindhu et al 2021). Several products of marine organisms, including microalgae, exhibit immunomodulatory activity (Singh and Krishna 2019). Indonesia has been known as a maritime country that is rich in biodiversity of organisms, including marine organisms and microalgae.…”
Section: Introductionmentioning
confidence: 99%